Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-536 (Azilsartan) in Pediatric Hypertension (2 to <6 Years)
NCT04668157Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azilsartan in hypertension (HTN), sponsored by Takeda. Started May 2021; status: completed.
02
Drugs
azilsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04668157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04668157.